Oppenheimer analyst issues OUTPERFORM recommendation for PNR on February 4, 2026 01:33PM ET. The previous analyst recommendation was Outperform.PNR was trading at $94.79 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues OVERWEIGHT recommendation for CMG on February 4, 2026 01:34PM ET. The previous analyst recommendation was Overweight.CMG was trading at $39.175 at issue of the analyst recommendation.The...
Oppenheimer analyst issues OUTPERFORM recommendation for GWW on February 4, 2026 01:31PM ET. The previous analyst recommendation was Outperform.GWW was trading at $1155 at issue of the analyst recommendation.The overall...
RBC Capital analyst issues OUTPERFORM recommendation for J on February 4, 2026 01:35PM ET. The previous analyst recommendation was Outperform.J was trading at $132.91 at issue of the analyst recommendation.The...
Oppenheimer analyst issues OUTPERFORM recommendation for GAIN on February 4, 2026 01:35PM ET. The previous analyst recommendation was Outperform.GAIN was trading at $13.74 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues OVERWEIGHT recommendation for ETN on February 4, 2026 01:38PM ET. The previous analyst recommendation was Overweight.ETN was trading at $362.53 at issue of the analyst recommendation.The...
RBC Capital analyst issues OUTPERFORM recommendation for MRCY on February 4, 2026 01:35PM ET. The previous analyst recommendation was Outperform.MRCY was trading at $99.28 at issue of the analyst recommendation.The...
Lake Street analyst issues BUY recommendation for TATT on February 4, 2026 01:43PM ET. The previous analyst recommendation was Buy.TATT was trading at $48.72 at issue of the analyst recommendation.The...
Cowen & Co. analyst issues BUY recommendation for CPRI on February 4, 2026 01:44PM ET. The previous analyst recommendation was Buy.CPRI was trading at $20.08 at issue of the analyst...
RBC Capital analyst issues OUTPERFORM recommendation for EMR on February 4, 2026 01:45PM ET. The previous analyst recommendation was Outperform.EMR was trading at $152.1 at issue of the analyst recommendation.The...
